Jazz Pharmaceuticals PLC Company Profile (NASDAQ:JAZZ)

Analyst Ratings

Consensus Ratings for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) (?)
Ratings Breakdown: 1 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.93)
Consensus Price Target: $185.36 (30.62% upside)

Analysts' Ratings History for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Show:
DateFirmActionRatingPrice TargetActions
7/19/2016MizuhoBoost Price TargetBuy$193.00 -> $195.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016BMO Capital MarketsInitiated CoverageOutperform$190.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2016Leerink SwannReiterated RatingOutperform$200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Piper Jaffray Cos.Reiterated RatingOverweight$186.00 -> $188.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Goldman Sachs Group Inc.Initiated CoverageNeutral -> Buy$196.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2016SunTrust Banks Inc.Reiterated RatingBuy$200.00 -> $210.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Canaccord GenuityReiterated RatingBuy$170.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Northland SecuritiesReiterated RatingOutperform$175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/19/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Stifel NicolausLower Price TargetBuy$225.00 -> $200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2015Sanford C. BernsteinInitiated CoverageMarket Perform$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015GuggenheimBoost Price TargetBuy$210.00 -> $220.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015Cantor FitzgeraldSet Price TargetBuy -> Hold$175.00 -> $165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Citigroup Inc.Initiated CoverageBuy$195.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014R. F. LaffertyUpgradeNeutral -> Buy$200.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014S&P Equity ResearchInitiated CoverageHold -> Average$43.66 -> $42.19View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2014FBR & CoLower Price Target$214.00 -> $213.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/10/2016Q1$2.31$2.26$338.86 million$336.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415$2.60$2.60$349.98 million$340.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315$2.56$2.52$348.15 million$340.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$2.41$2.41$335.58 million$333.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$2.15$1.99$309.50 million$309.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414$2.30$2.44$319.74 million$328.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314$2.23$2.33$302.90 million$306.58 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$1.92$2.05$273.39 million$291.23 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114$1.79$1.61$254.86 million$247.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q413$1.78$1.72$238.12 million$235.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$1.67$1.78$227.38 million$232.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$1.52$1.43$208.71 million$208.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013$1.35$1.37$189.92 million$196.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$1.41$1.53$183.80 million$183.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312$1.31$1.29$178.57 million$175.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$1.05$1.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012$0.90$0.91ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.89$0.94ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.67$0.82ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.57$0.59ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/7/2011$0.60$0.63ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$1.39$1.48$1.44
Q2 20161$1.92$1.92$1.92
Q3 20164$1.88$2.16$2.01
Q4 20162$2.38$2.70$2.54
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/15/2016Michael Patrick MillerSVPSell100$142.43$14,243.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2016Karen L SmithCMOBuy580$143.63$83,305.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2016Michael Patrick MillerSVPSell100$149.64$14,964.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2016Karen L SmithCMOBuy557$149.61$83,332.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Heather Ann McsharryDirectorSell697$145.20$101,204.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Michael Patrick MillerSVPSell100$145.20$14,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016Karen J WilsonSVPSell604$160.00$96,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016Michael Patrick MillerSVPSell100$145.79$14,579.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2016Karen J WilsonSVPSell5,007$150.00$751,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/12/2016Russell J CoxCOOSell4,000$136.98$547,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2016Karen J WilsonSVPSell2,161$140.90$304,484.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/15/2016Michael Patrick MillerSVPSell100$129.17$12,917.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/8/2016Bruce C CozaddCEOSell2,500$126.04$315,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Paul TreacySVPSell354$123.48$43,711.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2016Seamus MulliganDirectorSell27,968$122.71$3,431,953.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016Michael Patrick MillerSVPSell100$115.63$11,563.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Patrick G EnrightDirectorSell10,000$117.92$1,179,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Bruce C CozaddCEOSell2,500$111.37$278,425.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2016Michael Patrick MillerSVPSell100$122.66$12,266.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016Bruce C CozaddCEOSell2,500$123.81$309,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2016Patrick G EnrightDirectorSell10,000$138.09$1,380,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Michael Patrick MillerSVPSell100$136.99$13,699.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Bruce C CozaddCEOSell2,500$139.72$349,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Patrick G EnrightDirectorSell10,424$146.67$1,528,888.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/23/2015Seamus MulliganDirectorSell27,968$145.86$4,079,412.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Bruce C CozaddCEOSell2,500$128.53$321,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Patrick G EnrightDirectorSell10,000$135.29$1,352,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2015Suzanne Sawochka HooperEVPSell2,000$125.00$250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2015Bruce C CozaddCEOSell2,500$131.50$328,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Patrick G EnrightDirectorSell10,000$133.79$1,337,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2015Michael Patrick MillerSVPSell100$145.23$14,523.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015Bruce C. CozaddCEOSell2,500$163.07$407,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/1/2015Patrick G EnrightDirectorSell10,000$165.99$1,659,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Bruce C CozaddCEOSell5,000$177.79$888,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2015Suzanne Sawochka HooperEVPSell4,000$177.79$711,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2015Patrick G EnrightDirectorSell10,000$177.11$1,771,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Bruce C CozaddCEOSell5,000$173.16$865,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Suzanne Sawochka HooperEVPSell4,000$173.16$692,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2015Karen J WilsonSVPSell5,751$179.59$1,032,822.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Karen J WilsonSVPSell5,494$179.57$986,557.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015Bruce C CozaddCEOSell5,000$181.45$907,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015Suzanne Sawochka HooperEVPSell4,000$181.45$725,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Seamus MulliganDirectorSell50,000$174.59$8,729,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Patrick G EnrightDirectorSell10,000$160.25$1,602,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014Seamus MulliganDirectorSell50,000$163.40$8,170,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Patrick G EnrightDirectorSell2,343$170.98$400,606.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Bruce C CozaddCEOSell5,000$178.79$893,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Suzanne Sawochka HooperEVPSell1,852$178.79$331,119.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Patrick G EnrightDirectorSell10,000$172.74$1,727,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Jeffrey K TobiasCMOSell4,598$170.12$782,211.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Iain McgillSVPSell7,066$172.03$1,215,563.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2014Jeffrey K TobiasCMOSell1,000$154.04$154,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Patrick G EnrightDirectorSell10,000$160.56$1,605,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2014Seamus MulliganDirectorSell50,000$163.16$8,158,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2014Seamus MulliganDirectorSell35,294$163.70$5,777,627.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Jeffrey K TobiasCMOSell1,000$171.22$171,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014Karen J WilsonSVPSell3,000$175.00$525,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014Seamus MulliganDirectorSell50,000$175.00$8,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2014Bruce C CozaddCEOSell5,000$170.32$851,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Karen J WilsonSVPSell2,500$170.00$425,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014Suzanne Sawochka HooperEVPSell1,852$168.00$311,136.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Bruce C CozaddCEOSell5,000$133.15$665,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Suzanne Sawochka HooperEVPSell1,185$133.15$157,782.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Jeffrey K TobiasCMOSell4,933$135.42$668,026.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2014Bruce C CozaddCEOSell5,000$155.00$775,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2014Suzanne Sawochka HooperEVPSell1,853$155.00$287,215.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Karen J WilsonSVPSell2,500$165.00$412,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Seamus MulliganDirectorSell50,000$149.69$7,484,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Russell J CoxCOOSell2,000$155.00$310,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014Fintan KeeganEVPSell3,750$150.00$562,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Bruce C CozaddCEOSell5,000$142.34$711,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Jeffrey TobiasCMOSell1,000$128.01$128,010.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Bruce CozaddCEOSell5,000$128.92$644,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2014Rick WinninghamDirectorSell27,500$140.00$3,850,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Jeffrey TobiasCMOSell3,000$128.54$385,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014Bruce CozaddCEOSell5,000$123.18$615,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Jeffrey TobiasCMOSell3,000$152.99$458,970.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Fintan KeeganEVPSell4,640$159.90$741,936.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Seamus MulliganDirectorSell550,000$156.25$85,937,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Patrick EnrightDirectorSell559,628$152.39$85,281,710.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)
DateHeadline
07/27/16 07:35 AMCan Shares Of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Hit $210? - Investor Newswire
07/26/16 07:43 AMJazz Pharmaceuticals plc (JAZZ) Shares are Down -0.3% - Trade Calls
07/25/16 04:52 PMJazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9 ...
07/25/16 03:18 PMJazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016 - [at noodls] - DUBLIN, July 25, 2016 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2016 second quarter financial results on Tuesday, August 9, 2016, after the close of ...
07/24/16 04:22 PMUpdated Analysts Rating Report: Express Scripts Holding Company (NASDAQ:ESRX) , Jazz Pharmaceuticals plc ... - Street Updates
07/22/16 11:05 AMWhat Is An Options Sweep? -
07/20/16 02:49 PMIs $210 Price Target Attainable For Jazz Pharmaceuticals plc (NASDAQ:JAZZ)? - Investor Newswire
07/19/16 04:49 PMA Brexit Boondoggle for the Ireland ETF
07/19/16 04:49 PMInsider Trading Activity – Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
07/17/16 09:06 AMPartner Fund Management LP Increased Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) by $32.83 Million as Shares ... - Press Telegraph
07/15/16 08:39 AMCrowd Rating and Earnings Recap for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Telanagana Press
07/15/16 08:39 AMPutnam Investments LLC Decreased Stake in Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) by $5.16 Million as Shares ... - Consumer Eagle
07/15/16 08:39 AMBulls Crowd Into Jazz Pharmaceuticals For Good Reason - Forbes
07/15/16 08:17 AMBulls Crowd Into Jazz Pharmaceuticals For Good Reason -
07/15/16 08:06 AMJazz Pharmaceuticals: How Much Return Potential Does It Have? -
07/14/16 04:57 PMJazz Pharmaceuticals plc (NASDAQ:JAZZ) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/14/16 04:57 PMWestfield Capital Management Company LP Decreased Stake in Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) by $58.24 ... - Consumer Eagle
07/14/16 10:08 AMA Look at Celator’s Lead Drug Vyxeos -
07/14/16 08:18 AMJazz Pharmaceuticals plc (NASDAQ:JAZZ) Trading Down – Insider Trading Activity
07/13/16 05:07 PMIreland Revises Up 2015 Growth To 26.3%
07/13/16 05:06 PM‘Leprechaun Economics’ Earn Ireland Ridicule, $443 Million Bill
07/13/16 05:06 PMIreland's Economists Left Speechless by 26 Percent Growth Figure
07/13/16 05:06 PMFive things you should know before you start your work day on July 13
07/13/16 07:39 AMStrong Sell Calls For Jazz Pharmaceuticals plc (NASDAQ:JAZZ) At 0 - Investor Newswire
07/13/16 07:39 AMJazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common ... - PR Newswire (press release)
07/12/16 04:58 PMIreland ETF Not Matching Robust Economic Growth
07/12/16 04:58 PMTwenty-six per cent GDP growth isn’t all it’s cracked up to be — just ask Ireland
07/12/16 04:58 PMSpot The Year Of The Tax Inversion
07/12/16 03:04 PMJAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct -
07/12/16 09:06 AMJazz Pharmaceuticals (JAZZ) Offers Results from Celator Pharma (CPXX) Tender Offer
07/09/16 08:08 AMLarge Inflow of Money Witnessed in Jazz Pharmaceuticals plc - TheFounders Daily
07/08/16 04:54 PMJAZZ August 26th Options Begin Trading
07/08/16 07:39 AMWall Street Ratings and Target Price Views on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Telanagana Press
07/07/16 07:38 AMJazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/07/16 07:38 AMStock Rating Watch and Earnings Insight for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Press Telegraph
07/07/16 07:38 AMBMO Capital Initiates Coverage on Jazz Pharmaceuticals plc - Ordinary Shares to Outperform - TheFounders Daily
07/05/16 04:37 PMThis Weeks Broker Price Targets For Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) - Fiscal Standard
07/05/16 04:37 PMJazz Pharmaceuticals plc (NASDAQ:JAZZ) Expected to Reach Highs Of $210 - Investor Newswire
07/01/16 04:44 PMSell-Side Recommendation & Price Target Projections on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Telanagana Press
07/01/16 04:44 PMJazz Pharmaceuticals Plc (NASDAQ:JAZZ) Current Analyst Ratings - Fiscal Standard
06/30/16 04:59 PMAnalysts and Technical Insights on Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) - Street Report
06/30/16 07:37 AMJazz Pharmaceuticals plc (NASDAQ:JAZZ) Company Rating and Target Watch - Telanagana Press
06/29/16 04:39 PMCelator Investor Looks To Block $1.5B Jazz Pharma Deal
06/29/16 03:25 PMJazz Pharma (JAZZ) Stock Receives 'Outperform' Rating at BMO Capital -
06/29/16 07:35 AMShare Update and Earnings Review for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - Press Telegraph
06/29/16 07:35 AMJazz Pharmaceuticals Plc (NASDAQ:JAZZ) Updated Price Targets - FTSE News
06/28/16 04:41 PMStrong Sell Calls Recommendations For Jazz Pharmaceuticals plc (NASDAQ:JAZZ) At 0 - Investor Newswire
06/27/16 04:42 PMJazz Pharmaceuticals plc (NASDAQ:JAZZ) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 04:42 PMJazz Pharmaceuticals Plc Ireland (NASDAQ:JAZZ) Short Interest Increased By 45.33% - Press Telegraph
06/27/16 04:42 PMToday's Hot List: Southwestern Energy Company (NYSE:SWN), Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ ... - KC Register

Social

About Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC logoJazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on the development and commercialization of pharmaceutical products to meet unmet medical needs in neurology and psychiatry. As of December 31, 2009, the Company markets two products: Xyrem (sodium oxybate) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; and Luvox CR (fluvoxamine maleate) for the treatment of both obsessive compulsive disorder and social anxiety disorder. Its marketed products and late-stage product candidate are Xyrem (sodium oxybate) oral solution, Luvox CR (fluvoxamine maleate) Extended-Release Capsules and JZP-6 (sodium oxybate). Its other product candidates in clinical development are oral tablet forms of sodium oxybate; JZP-8 (intranasal clonazepam); JZP-4 (elpetrigine), and JZP-7 (ropinirole gel).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: JAZZ
  • CUSIP: G5087110
Key Metrics:
  • Previous Close: $141.91
  • 50 Day Moving Average: $143.26
  • 200 Day Moving Average: $136.95
  • P/E Ratio: 26.77
  • P/E Growth: 0.69
  • Market Cap: $8.57B
  • Beta: 0.71
  • Current Year EPS Consensus Estimate: $11.14 EPS
  • Next Year EPS Consensus Estimate: $12.87 EPS
Additional Links:
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Chart for Wednesday, July, 27, 2016